Business Context and Reporting Period
This Form 6-K filing by Sequans Communications S.A. covers the month of June 2025. The report addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the Company's compliance with continued listing standards.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin figures. However, it discloses the following financial conditions triggering the listing notice:
- Market Capitalization: The average global market capitalization over a consecutive 30 trading-day period was below $50,000,000.
- Stockholders' Equity: Stockholders' equity was less than $50,000,000.
Material Changes and Listing Status
On June 9, 2025, the Company received a "Notice of Failure to Satisfy Continued Listing Rules" from the NYSE due to a "Market Cap Deficiency" under Section 802.01B of the NYSE Listed Company Manual. Key developments include:
- Trading Status: The Company's ADSs will continue to trade on the NYSE under the symbol "SQNS" but will carry a ".BC" designation to indicate "below compliance."
- Immediate Impact: The notice does not result in immediate delisting.
- Compliance Timeline: The Company has 90 days from receipt of the notice to submit a business plan to the NYSE. If accepted, the Company has a 9-month "Market Cap Cure Period" to regain compliance.
Management Commentary and Outlook
Management has notified the NYSE of its intent to cure the deficiency and return to compliance. The Company is currently evaluating available options and developing a plan to meet the minimum global market capitalization requirement. A press release announcing the receipt of the notice was issued on July 9, 2025.
Investor Verification Checklist
- Verify the current trading status and the ".BC" designation on the NYSE for symbol SQNS.
- Monitor the submission of the Company's business plan to the NYSE within the 90-day window.
- Review upcoming financial reports to assess progress toward the $50,000,000 market capitalization and stockholders' equity thresholds.
- Check for any additional press releases or filings regarding the outcome of the NYSE's review of the cure plan.